Vit-Immune

Vit-Immune is a biotechnology company based in Blacksburg, Virginia, specializing in the discovery and development of immunometabolic therapies for inflammatory and autoimmune diseases. Founded by researchers from Virginia Tech, the company utilizes a proprietary platform that integrates computational modeling with experimental immunology to identify compounds that modulate key regulatory pathways, such as LANCL2 and PPAR-gamma. Its primary research focus involves the therapeutic potential of Abscisic Acid (ABA) for managing glycemic control and systemic inflammation in conditions like Type 2 diabetes and metabolic syndrome. Vit-Immune operates as part of a cluster of life science entities, including BioTherapeutics Inc., and has been instrumental in the early-stage development of novel anti-inflammatory agents.